Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00027066 · ClinicalTrials.gov registry record · Phase 3
Warfarin Versus Aspirin Recurrent Stroke Study
A Phase 3 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,206
- Enrollment target
NCT00027066: Completed Phase 3 study, sponsored by Columbia University.
NCT00027066 is a Phase 3 study that has completed, run by Columbia University. The registered enrollment target is 2,206 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (186% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00027066, a Phase 3 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,206 participants
- Enrollment target
Study Summary
The goal of this study is to compare aspirin to warfarin for the prevention of recurrent stroke.
Interventions
- DRUG Aspirin placebo
- DRUG Active Aspirin
- DRUG Active Warfarin
- DRUG Warfarin placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,206 participants |
| Start Date | 1993-06 |
| Est. Completion | 2001-11 |
| Phase | Phase 3 |
What the finished NCT00027066 record still lists
NCT00027066 is an interventional study that assigns participants to a tested intervention. Its 2,206 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (186% higher).
The record links to 0 conditions, and to 4 interventions - of which Aspirin placebo is the first listed.
NCT00027066 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00027066 about?
NCT00027066 is a clinical study titled "Warfarin Versus Aspirin Recurrent Stroke Study". The goal of this study is to compare aspirin to warfarin for the prevention of recurrent stroke.
What is the current status of trial NCT00027066?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,206 participants. The study started on 1993-06. Estimated completion is 2001-11.
What interventions are being tested in trial NCT00027066?
The interventions under investigation include: Aspirin placebo (DRUG), Active Aspirin (DRUG), Active Warfarin (DRUG), Warfarin placebo (DRUG).
Who is sponsoring clinical trial NCT00027066?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00027066's enrollment target sits among peer trials
2,206 95th of 2000 higher than 1,906 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- NCT06526988 · 2,200 participants · NA
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
- NCT06682650 · 2,200 participants · NA
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia